Antimicrobial agents and chemotherapy

• 

  Año 2006, Vol. 50, Número 4

  • beta-Lactamase Nomenclature

    G. A. Jacoby

    págs. 1123-1129

    

  • Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Acetyltransferase-2, and Xanthine Oxidase Activities in Healthy Adults

    A. N. Nafziger, J. D. Ma

    págs. 1130-1135

    

  • Structure-Activity Relationships of Aminocoumarin-Type Gyrase and Topoisomerase IV Inhibitors Obtained by Combinatorial Biosynthesis

    A. Eustaquio, R. H. Flatman

    págs. 1136-1142

    

  • Organization of Tn2610 Containing Two Transposition Modules

    A. Takaya, T. Yamamoto, M. Watanabe

    págs. 1143-1147

    

  • Overexpression of Candida albicans CDR1, CDR2, or MDR1 Does Not Produce Significant Changes in Echinocandin Susceptibility

    K. Maki, A. R. Holmes, F. Ikeda, K. Niimi

    págs. 1148-1155

    

  • Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus Isolates

    C. Kehrenberg

    págs. 1156-1163

    

  • Comparing Gatifloxacin and Clarithromycin in Pneumonia Symptom Resolution and Process of Care

    N. C. Dean, M. S. Suchyta, P. Sperry, M. Wikler

    págs. 1164-1169

    

  • Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients

    H. McIlleron

    págs. 1170-1177

    

  • qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance

    G. A. Jacoby, K. E. Walsh, V. J. Walker, D. M. Mills

    págs. 1178-1182

    

  • Staphylococcus aureus CcpA Affects Virulence Determinant Production and Antibiotic Resistance

    K. Seidl, M. Stucki

    págs. 1183-1194

    

  • Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum and Treated with a New Amphotericin B Formulation

    S. R. Iniguez, M. A. Dea Ayuela, J. A. Sanchez Brunete

    págs. 1195-1201

    

  • Bac 32, a Novel Bacteriocin Widely Disseminated among Clinical Isolates of Enterococcus faecium

    Takako Inoue, H. Tomita

    págs. 1202-1212

    

  • Gentamicin Causes Apoptosis at Low Concentrations in Renal LLC-PK~1 Cells Subjected to Electroporation

    H. Servais, Y. Jossin, F. van Bambeke

    págs. 1213-1221

    

  • Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults

    A. N. Nafziger, M. Chen

    págs. 1222-1227

    

  • In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class

    J. D. Parsons, N. Mani, C. H. Gross

    págs. 1228-1237

    

  • Nanodisk-Associated Amphotericin B Clears Leishmania major Cutaneous Infection in Susceptible BALB/c Mice

    K. G. Nelson, J. V. Bishop

    págs. 1238-1244

    

  • Rapid Microbiologic and Pharmacologic Evaluation of Experimental Compounds against Mycobacterium tuberculosis

    K. S. Marietta, C. M. Johnson, V. Gruppo

    págs. 1245-1250

    

  • Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii: Molecular Basis for the Differential Mechanisms of Action

    M. J. Rodriguez Hernandez, J. M. Saugar

    págs. 1251-1256

    

  • Clinical and Economic Impact of Bacteremia with Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae

    M. J. Schwaber, S. Navon-Venezia

    págs. 1257-1262

    

  • Garenoxacin Treatment of Experimental Endocarditis Caused by Viridans Group Streptococci

    P. Anguita Alonso

    págs. 1263-1267

    

  • Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis

    R. M. Donlan, J. J. Curtin

    págs. 1268-1275

    

  • MepR, a Repressor of the Staphylococcus aureus MATE Family Multidrug Efflux Pump MepA, Is a Substrate-Responsive Regulatory Protein

    C. E. DeMarco, G. W. Kaatz

    págs. 1276-1281

    

  • In Vitro Analysis of ISEcp1B-Mediated Mobilization of Naturally Occurring beta-Lactamase Gene bla~C~T~X~-~M of Kluyvera ascorbata

    M. F. Lartigue

    págs. 1282-1286

    

  • Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

    B.A. Arthington Skaggs, B. J. Park

    págs. 1287-1292

    

  • Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

    K. V. Clemons

    págs. 1293-1297

    

  • Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resistant Staphylococcus aureus in a Mixed-Pathogen Pharmacodynamic Model

    K. L. LaPlante

    págs. 1298-1303

    

  • Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady State

    G. E. Chittick

    págs. 1304-1310

    

  • Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole

    A. Lepak, J. Nett, L. Lincoln, K. Marchillo

    págs. 1311-1319

    

  • Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication

    F. Puig Basagoiti

    págs. 1320-1329

    

  • Novel Carbapenem-Hydrolyzing Oxacillinase OXA-62 from Pandoraea pnomenusa

    A. Bauernfeind, I. Schneider, A. M. Queenan

    págs. 1330-1335